Coronary disease & ACSGuideline or statement
2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease
- Clinical performance and quality measure set
Recommendations
As issued by the authors
Assessment of tobacco use and evidence-based cessation interventions
Antiplatelet therapy, lipid assessment and LDL-C goals, and guideline-directed management and therapy for hypertension and reduced LV dysfunction in chronic coronary disease (CCD)
Cardiac rehabilitation referral and patient education, including symptom management and lifestyle modification
Original publication
2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease. J Am Coll Cardiol. Published 30 April 2025. doi:10.1016/j.jacc.2025.02.001
Summarised from the published abstract; every number is checked against it